These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 1193115

  • 21. SC-36602, a new antiarrhythmic agent: comparison of its cardiovascular profile with that of other antiarrhythmic drugs.
    Frederick LG, Hatley FR, McDonald SJ, Stamm MH, Garthwaite SM.
    J Cardiovasc Pharmacol; 1988 Jun; 11(6):657-66. PubMed ID: 2457760
    [Abstract] [Full Text] [Related]

  • 22. Cardiovascular and neuromuscular effects of Org NC 45, pancuronium, metocurine, and d-tubocurarine in dogs.
    Booij LH, Edwards RP, Sohn YJ, Miller RD.
    Anesth Analg; 1980 Jan; 59(1):26-30. PubMed ID: 7188662
    [Abstract] [Full Text] [Related]

  • 23. [Effects of aprindine (AC 1802) on myocardial function in man].
    Besse P, Choussat A.
    Acta Cardiol; 1974 Jan; Suppl 18():217-31. PubMed ID: 4547426
    [No Abstract] [Full Text] [Related]

  • 24. Comparative cardiovascular effects of verapamil, nifedipine, and diltiazem during halothane anesthesia in swine.
    Kates RA, Zaggy AP, Norfleet EA, Heath KR.
    Anesthesiology; 1984 Jul; 61(1):10-8. PubMed ID: 6742468
    [Abstract] [Full Text] [Related]

  • 25. [The cardiovascular effect of Cordemcura on various animal models in vivo].
    Rohde E, Muschick P, Modersohn D, Landmann H, Löwe H.
    Pharmazie; 1986 Mar; 41(3):194-5. PubMed ID: 3714794
    [Abstract] [Full Text] [Related]

  • 26. Antiarrhythmic effect of aprindine on several types of ventricular arrhythmias.
    Ueda M, Kimoto S, Matsuda S, Kawakami M, Mroishige E, Matsumura S, Takeda H.
    Jpn J Pharmacol; 1975 Oct; 25(5):549-61. PubMed ID: 1221137
    [Abstract] [Full Text] [Related]

  • 27. N-n-propyl-ajmaline-bitartrate (NPAB), a new antiarrhythmic drug. Comparative studies on the antifibrillatory and hemodynamic effects in the anaesthetised cat.
    Diederich KW, Boyksen D.
    Arzneimittelforschung; 1973 Sep; 23(9):1302-5. PubMed ID: 4801225
    [No Abstract] [Full Text] [Related]

  • 28. [Effect of the class IA anti-arrhythmic agents ajmaline on end-systolic pressure-volume relations (conductance technique)].
    Thormann J, Hüting J, Kremer P, Mitrovic V, Wissemann J, Bahawar H, Schlepper M.
    Z Kardiol; 1990 Oct; 79(10):706-16. PubMed ID: 2087858
    [Abstract] [Full Text] [Related]

  • 29. Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.
    Brown BS, Calzadilla SV, Diemer MJ, Hartman JC, Reynolds RD.
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1225-34. PubMed ID: 3694532
    [Abstract] [Full Text] [Related]

  • 30. [Effects of intravenous aprindine on hemodynamics in patients with cardiac dysfunction and its pharmacodynamics in patients with premature ventricular contractions].
    Matsumoto N, Hayasaki K.
    Kokyu To Junkan; 1990 Apr; 38(4):383-9. PubMed ID: 1694595
    [Abstract] [Full Text] [Related]

  • 31. Long-term oral antiarrhythmic therapy with aprindine: effects on cardiac function and adverse effects.
    Tsutsui H, Araki H, Nagata Y, Nakamura M.
    Clin Ther; 1984 Apr; 6(6):770-7. PubMed ID: 6509460
    [Abstract] [Full Text] [Related]

  • 32. Effects of magnesium chloride on cardiovascular hemodynamics in the neurally intact dog.
    Friedman HS, Nguyen TN, Mokraoui AM, Barbour RL, Murakawa T, Altura BM.
    J Pharmacol Exp Ther; 1987 Oct; 243(1):126-30. PubMed ID: 3668845
    [Abstract] [Full Text] [Related]

  • 33. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W.
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [Abstract] [Full Text] [Related]

  • 34. Hemodynamic effects of verapamil and practolol in man.
    Seabra-Gomes R, Rickards A, Sutton R.
    Eur J Cardiol; 1976 Mar; 4(1):79-85. PubMed ID: 1261583
    [Abstract] [Full Text] [Related]

  • 35. [Changes in hemodynamics and contractility during supraventricular tachycardias and after electrical or aprindin-induced termination (author's transl)].
    Weppner HG, Merle H, Schlepper M.
    Arzneimittelforschung; 1976 Mar; 26(12):2205-8. PubMed ID: 1037277
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Pharmacological evaluation of aprindine (AC 1802) a new antiarrhythmic agent.
    Georges A, Hosslet A, Duvernay G.
    Acta Cardiol; 1973 Mar; 28(2):166-91. PubMed ID: 4540792
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Electrophysiology and pharmacology of aprindine, encainide, and propafenone.
    Zipes DP, Prystowsky EN, Heger JJ.
    Ann N Y Acad Sci; 1984 Mar; 432():201-9. PubMed ID: 6441495
    [No Abstract] [Full Text] [Related]

  • 40. Effect of sotalol, aprindine and the combination aprindine-sotalol on monophasic action potential duration.
    Stroobandt R, Brachmann J, Kesteloot H, Kübler W, Senges J.
    Eur Heart J; 1986 Jan; 7(1):47-53. PubMed ID: 3956522
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.